RETINA WORLD CONGRESS: Diabetic Macular Edema Clinical Trials Lack Patient Diversity

When it comes to medical research, diversity, equity, and inclusion need to be larger parts of the conversation. As it stands now, medical research can be fiercely hierarchical, expensive, and homogenous in terms of…

Continue Reading RETINA WORLD CONGRESS: Diabetic Macular Edema Clinical Trials Lack Patient Diversity
A Newly Initiated Phase 1 Study Will Evaluate AIV007 for Wet AMD, DME 
Skitterphoto / Pixabay

A Newly Initiated Phase 1 Study Will Evaluate AIV007 for Wet AMD, DME 

  In late May 2023, clinical-stage biotechnology company AiViva Biopharma Inc. ("AiViva") shared via news release that the company had launched a Phase 1 clinical study evaluating AIV007 for diabetic…

Continue Reading A Newly Initiated Phase 1 Study Will Evaluate AIV007 for Wet AMD, DME 
Vabysmo Shows Advantages Over Aflibercept in Wet AMD and Diabetic Macular Edema
source: pixabay.com

Vabysmo Shows Advantages Over Aflibercept in Wet AMD and Diabetic Macular Edema

An announcement from the drug company Genentech highlights the results of a recent study which demonstrated that the drug faricimab-svoa (marketed at Vabysmo) was able to dry retinal fluid more…

Continue Reading Vabysmo Shows Advantages Over Aflibercept in Wet AMD and Diabetic Macular Edema